Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4860 results found.

Example of search result explained

Trosec

Exceptional medication
  • Active ingredient(s):
    trospium chloride
  • Manufactured by:
    Sunovion Pharmaceuticals Canada Inc. (Sunovion)
  • Strength and dosage form:
    Tablet 20 mg DIN : 2275066

Rinvoq

Exceptional medication
  • Active ingredient(s):
    upadacitinib
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    • Long-Action Tablet 15 mg DIN : 2495155
    • Long-Action Tablet 30 mg DIN : 2520893
    • Long-Action Tablet 45 mg DIN : 2539721

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (ulcerative colitis and Crohn's disease)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114312
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114314
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2544210
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114313
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 99114443
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 99114444

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2544180
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2544199
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 2544202
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 2553317
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 2553309

Jamteki

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2543036
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2543044

Steqeyma

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2550245
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2550253

Entyvio

Exceptional medication
  • Active ingredient(s):
    vedolizumab
  • Manufactured by:
    Takeda Canada Inc. (Takeda)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 300 mg DIN : 2436841

Entyvio (syringe)

Exceptional medication
  • Active ingredient(s):
    vedolizumab
  • Manufactured by:
    Takeda Canada Inc. (Takeda)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 108 mg/0.68 mL DIN : 2497875

Entyvio (stylo)

Exceptional medication
  • Active ingredient(s):
    vedolizumab
  • Manufactured by:
    Takeda Canada Inc. (Takeda)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 108 mg/0.68 mL DIN : 2497867

Zelboraf

Exceptional medication
  • Active ingredient(s):
    vemurafenib
  • Manufactured by:
    Hoffmann-La Roche Ltée (Roche)
  • Strength and dosage form:
    Tablet 240 mg DIN : 2380242
Page 131 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.